A flash of light passed, and Norton immediately returned to his kind appearance, with a smile on his lips, and a happy look.

Jiang Lingyun came to his senses and immediately said, "Mr. Norton, I will arrange for someone to meet Chen Fei immediately."

After saying that, he paused and said, "But, we just broke down with Chen Fei. If we meet again, we may-"

Norton shook his head, waved his hand and interrupted Jiang Lingyun, saying, "No need to be so troublesome."

"Mr. Norton, you——" Jiang Lingyun was a little confused.

Norton smiled and said, "I'll visit Chen Fei in person."

"Peace in person!" Jiang Lingyun was stunned and said in surprise, "Mr. Norton, you--"

Norton stood up and said, "Go and call a taxi, we'll set off right away!"

………

Chen Fei, who came back after the talks, said goodbye to Tao Ling and Mr. Du. He just returned to the office and sat down. The secretary outside heard a message, "Mr. Chen, is there a guest outside who wants to see you?"

"Who?" Chen Fei asked.

The secretary said: "Jiang Lingyun, General Manager of Jianghuhai Pharmaceutical."

"Jiang Lingyun, why is he here?" Chen Fei frowned, wondering in his heart.

After all, their talks have just ended not long ago.

At this time, the secretary added: "There is another foreigner who said his name is Norton."

"Foreigner, Norton!" Chen Fei thought for a while and found that he did not know this foreigner named Norton. He couldn't help but feel curious, but he still waved his hand, "I don't want to see them, let them leave."

The secretary takes you, then turns around and goes out to convey the news.

But before the secretary could go out, he saw Jiang Lingyun and Norton walking towards him.

"Sir, you can't--" the secretary quickly stopped the two of them.

Jiang Lingyun shouted coldly: "I want to see you Mr. Chen!" Then he reached out and pushed the secretary away.

Seeing this, Chen Fei couldn't help but shout coldly and said, "Mr. Chen, this is not your Jianghuhai Pharmaceutical. It's best to restrain your behavior."

While speaking, Chen Fei waved his arm directly, and an invisible energy was sent out, directly knocking Jiang Lingyun back.

Jiang Lingyun staggered a few times and almost fell down.

Suddenly, his face was gloomy and his face was filled with anger. He glared at Chen Fei fiercely, "Chen Fei, you dare to attack me!"

Chen Fei said coldly: "This is my office. You broke in randomly. This is the lightest way of punishment. Otherwise, there will be even more ruthless people. Does Mr. Jiang want to try it?"

"You--" Jiang Lingyun was furious and couldn't help but burst out.

But at this time, Norton stood up with a smile and said to Chen Fei directly in Chinese: "Mr. Chen, I'm sorry, we are reckless."

"Now, I'm officially visiting Mr. Chen, don't you know if Mr. Chen is convenient for us to see us?" As he spoke, Norton handed a business card to the secretary.

The secretary took the business card to Chen Fei, and Chen Fei took a look at the contents on the business card.

When his eyes fell on the title of "General Manager of Bald Eagle Pharmaceutical Asia Region", his eyes couldn't help but move and looked at Norton.

Norton looked at Chen Fei with a smile, looking extremely confident.

Chen Fei was silent for a while, looked at Norton and said, "If you have anything to do, just say it."

Upon hearing this, Jiang Lingyun couldn't help but be furious and shouted to Chen Fei: "Chen Fei, what is your attitude?"

"Mr. Norton is a senior executive of Bald Eagle Pharmaceuticals. You are so negligent-"

Chen Fei said coldly: "I don't care if he is a bald eagle or a black eagle. This is my company. If you want to say something, just say it. If you don't say it, get out."

"You--" Jiang Lingyun pointed at Chen Fei, extremely furious.

However, Norton still smiled at the corner of his mouth, stopped Jiang Lingyun, then looked at Chen Fei and said, "Since Mr. Chen said that, I'll just say it."

"We Bald Eagle Pharmaceuticals want to cooperate with Mr. Chen. The cooperation content is the ephedra oral liquid that Mr. Chen just developed. We want to-"

Hearing this, Chen Fei frowned, waved his hand and interrupted Norton's words, saying, "If it was the acquisition of the patent for ephedra oral liquid, then there was no need to say it, I would not agree."

Norton smiled and said, "Mr. Chen, don't rush to refuse. Why not listen to our conditions before talking about it?"

"No matter what the conditions are, I will not agree." Chen Fei waved his hand.

Seeing this, Jiang Lingyun said angrily: "Chen Fei, this is Mr. Norton, it is Bald Eagle Pharmaceutical. This is your opportunity, you--"

Norton stopped Jiang Lingyun and said to Chen Fei: "I know that Chen is always smart and definitely understands the potential of ephedra oral liquid. So, I won't talk about those weak ones. I just said that our Bald Eagle Pharmaceutical wants the patent for ephedra oral liquid--"

"This is not--" Chen Fei waved his hand.

Before Chen Fei finished speaking, Norton said: "We are not going to buy out the patent for ephedra oral liquid, but we use the share model to cooperate with you, Mr. Chen."

"As long as Mr. Chen, you agree, we Bald Eagle Pharmaceutical will immediately pay Mr. Chen a $100 million fund. In the future, Mr. Chen can also obtain 5% of the profit of the drug."

When Chen Fei heard this condition, before he could react, Jiang Lingyun was shocked.

He is a man in the pharmaceutical industry and naturally knows the value of the conditions offered by Norton.

You should know that in the pharmaceutical industry, in major laboratories around the world, scientists develop many patented drugs every year, but due to the lack of production conditions and promotion conditions, these scientists and laboratories often sell the research patent results to major pharmaceutical companies.

Among them, there are generally two ways to sell.

One is a one-time buyout, directly transferring the drug patent rights to a pharmaceutical company, and the pharmaceutical company pays the bill in one lump sum. In the future, the drug patent rights will be completely owned by the pharmaceutical company and have no relationship with the developer.

The other is the share model. The pharmaceutical company first pays a portion of the property to the developer, and the subsequent distribution of profits is based on the profit of the drug in a certain proportion. That is, the more the drug is sold, the more profit the share will be.

In comparison, there is no doubt that the second share model has more potential. After all, once the drug is sold, the developer can make a certain profit from every benefit of selling one portion. The ultimate benefit will be longer and richer. It is much better than a one-time buyout.

Therefore, as long as developers who are a little confident in the prospects of their own drugs, they want to use the share model to sell patents and obtain more profits.

However, developers are aware of this, and pharmaceutical companies are naturally very clear about it.

Therefore, for most drug patents, almost all pharmaceutical companies use the first buyout method.
Chapter completed!